The top vaccine authority at the FDA has revealed a more stringent approach to federal vaccine approvals, triggered by concerns from his team linking Covid vaccines to the deaths of at least ten children. This shift is expected to complicate the vaccine approval process significantly.
Dr. Vinay Prasad, whose vaccine policy has gained backing from the US health secretary, shared with FDA staff that the agency would reassess its vaccination programs, as detailed in an internal email acquired by various media outlets. He indicated plans to review policies on annual flu shots, examine potential restrictions on simultaneous vaccinations, and demand more thorough safety and efficacy data from pharmaceutical companies prior to granting approvals.
The memo reportedly noted that a recent review found that at least ten children had died “after and because of” receiving a Covid vaccine, with these cases seemingly linked to myocarditis, an inflammation of the heart muscle. Prasad emphasized the significance of this finding, stating it was the first time the FDA would admit that Covid vaccines had been responsible for child deaths in the U.S.
He also indicated that new regulations would place stricter controls on vaccinations for pregnant women, signaling another major shift in the agency’s approval process. Prasad reportedly expressed willingness for thorough discussions and debates, mentioning that staff who disagreed with his fundamental principles should consider resigning.
A PBS NewsHour correspondent was the first to report on the contents of the memo. The New York Times highlighted that the document lacked specific details like the ages of the children involved, their pre-existing health conditions, or how the connection between vaccination and death was established. Additionally, the involved vaccine manufacturers weren’t specified.
Dr. Paul Offit from Children’s Hospital of Philadelphia reviewed the memo and labeled the approach as “dangerous and irresponsible.” He challenged the claim that the vaccine caused these deaths, arguing that such assertions require exceptional evidence and should be subjected to peer review before being announced.
Dr. Peter Marks, Prasad’s predecessor, expressed surprise at the “clearly political tone” of the communication and pointed out that the death reports warranted further investigation. He suggested the causes could be debatable, as these cases are often complex.
Current and former FDA employees, along with public health experts, have voiced concerns that this new strategy might severely hinder the vaccine development pipeline. The requirement for larger studies before approvals could lengthen timelines, making companies hesitant to expand vaccine development and could stifle innovation.
Furthermore, Prasad’s focus on reconsidering the simultaneous administration of vaccines could disrupt years of established federal guidance. The CDC currently supports administering multiple vaccines during a single visit for both children and adults, including flu, Covid, and RSV shots.
Dr. Kathryn Edwards, a vaccine specialist at Vanderbilt University, remarked that determining the cause of death in cases linked to vaccination is inherently complex. She suggested that without extensive investigation, one cannot definitively state that a vaccine caused a death, stressing the need for peer-reviewed insights before conclusions are made.
Edwards added that it’s crucial to remember that Covid-19 itself has led to many more child fatalities than the ten mentioned. She expressed her willingness to assess these cases thoroughly if given the evidence.
This new FDA framework echoes long-standing demands from Robert F Kennedy Jr. and groups opposing vaccines, who seek more substantial evidence of vaccine safety and efficacy. In August, the FDA set new restrictions regarding who can receive Covid vaccines, focusing on older individuals while being restrictive for younger populations unless specific health risks were present.
In September, Kennedy’s CDC advisory panel voted against recommending prescriptions for Covid-19 vaccines but acknowledged that vaccination decisions should be individualized. Recently it was reported that Ralph Abraham, a Louisiana health official critical of mass vaccination policies, was appointed as the new deputy director of the CDC.
Previous FDA leaders and independent scientists have highlighted that extensive testing, including pediatric studies, ensures Covid-19 vaccines are safe and effective. They contend that the benefits of vaccination overwhelmingly surpass the risks, which remain infrequent.
